CVS HEALTH Corp Buys 10,000 Shares of SPDR S&P Biotech ETF $XBI

CVS HEALTH Corp bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to the company in its most recent filing with the SEC. The firm bought 10,000 shares of the exchange traded fund’s stock, valued at approximately $1,577,000.

Several other hedge funds have also added to or reduced their stakes in the business. Wellington Management Group LLP bought a new position in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $19,270,000. Ayalon Insurance Comp Ltd. lifted its position in SPDR S&P Biotech ETF by 71.9% in the third quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock valued at $15,074,000 after purchasing an additional 40,000 shares during the last quarter. Maven Securities LTD bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $3,028,000. TD Waterhouse Canada Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 535.1% during the second quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock valued at $824,000 after purchasing an additional 4,436 shares during the period. Finally, Syon Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 67.9% during the second quarter. Syon Capital LLC now owns 23,562 shares of the exchange traded fund’s stock valued at $3,729,000 after purchasing an additional 9,530 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $156.31 on Thursday. SPDR S&P Biotech ETF has a 52-week low of $111.11 and a 52-week high of $169.89. The stock has a market capitalization of $10.55 billion, a price-to-earnings ratio of 11.47 and a beta of 0.87. The company’s 50 day moving average price is $154.82 and its 200-day moving average price is $142.69.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.